| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |